medline.ch Psychiatrie Schizophrenie und Psychosen

	Olanzapine in the treatment of schizophrenia in adolescents - mechanisms of action and therapeutic efficacy. Psychiatr Pol Nowak W, Korba P, Kinalska N, Kubik J, Lizo, Krzy. PMID: 41630413 [PubMed - indexed for MEDLINE]
	Living with psychosis and cognitive impairment: a qualitative study. BMC Psychiatry Landström T, Björkdahl A, Tyrberg MJ, Lindau M. PMID: 41629854 [PubMed - as supplied by publisher]
	Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [(11)C]UCB-J positron emission tomography study. Neuropsychopharmacology Onwordi EC, Whitehurst T, Shatalina E, Mansur A, Arumuham A, Osugo M, Marques TR, Jauhar S, Mehrotra R, Ranger M, Rahaman N, Church SM, Rabiner EA, Gunn RN, Natesan S, Reichenberg A, Howes OD. PMID: 41629634 [PubMed - as supplied by publisher]
	Analysis and prediction of schizophrenia patients based on high-order graph attention generative adversarial networks. Sci Rep Yin G, Yin M, Guo G, Yuan J, Ma X, Wang L, Zhao P, Shi D, Zhao Y, Zhao Z, Wang B, Tan S. PMID: 41629367 [PubMed - as supplied by publisher]
	Untargeted (1)H NMR-based metabolomics unveils distinct circulating biochemical signatures between treatment-resistant and non-treatment-resistant schizophrenia patients: a pilot study. Transl Psychiatry Marino C, Zhang S, De Simone G, Grimaldi M, Di Maio A, Iasevoli F, Errico F, D'Ursi AM, de Bartolomeis A, Usiello A. PMID: 41629277 [PubMed - as supplied by publisher]
	Incidence of psychotic disorders by birth cohort: a population-based cohort study in Ontario, Canada. CMAJ Myran DT, Gibb M, Pugliese M, Fiedorowicz JG, Anderson KK, Ramsay T, Jalal H, Kurdyak P, Solmi M. PMID: 41628942 [PubMed - indexed for MEDLINE]
	Episodic future thinking intervention in schizophrenia patients: Effects and neural correlates. Neuropsychologia Liu JL, Ye JY, Yang TX, Cui JF, Lai WH, He YL, Zhang P, Jiang ZJ, Chen T, Lui SSY, Chen GF, Zhang TJ, Wang Y, Chan RCK. PMID: 41628852 [PubMed - as supplied by publisher]
	[The new S3 guideline on schizophrenia (living) 2025]. Nervenarzt Halms T, Gaebel W, Leucht S, Falkai P, Lincoln T, Bechdolf A, Correll CU, Schmidt SJ, Lambert M, Wobrock T, Hasan A. PMID: 41627392 [PubMed - as supplied by publisher]
	Pharmacokinetics, efficacy, and safety of a novel aripiprazole microsphere-based long-acting injectable formulation for schizophrenia: A multicenter, randomized controlled trial. J Pharm Anal Li AN, Jin SC, Shang DW, Guo JX, Lin HL, Zhang M, Wei B, Wan F, Tan YL, Wang LL, Zhou JC, Liu P, Fan LL, Sun JS, Chen B, Cui Y, Wang G. PMID: 41626559 [PubMed]
	Efficacy of deep brain stimulation in treating the negative symptoms of treatment-resistant schizophrenia: Systematic review of human studies. Surg Neurol Int Nadeem SF, Jitender K, Waheed H, Gauhar F, Mirza FA, Khan AA. PMID: 41625102 [PubMed]
	Parabacteroides distinguishes bipolar disorder from schizophrenia: toward a microbial biomarker for differential diagnosis. Front Microbiol Majie W, Yifang H, Yuncui H, Yaping C, Longhui L, Qianyan J, Weiwei X, Wei C, Yucheng W. PMID: 41623645 [PubMed]
	Placebo and Nocebo Phenomena in Schizophrenia Spectrum Disorders: A Narrative Review on Current Knowledge and Potential Future Directions - CORRIGENDUM. Psychol Med Pujji SD, Colloca L, Waltz JA. PMID: 41623108 [PubMed - in process]
	Childhood Maltreatment and Social Cognition Deficits Across the Psychosis Spectrum: Evidence From the PREGAP Study. Span J Psychiatry Ment Health Pedruzo B, Aymerich C, de Pablo GS, Rodríguez-Sánchez JM, Gil P, MSc LM, Acasuso G, Arnaiz A, González-Pinto A, Alonso-Alconada D, Torres MÁG, Catalán A. PMID: 41621753 [PubMed - as supplied by publisher]
	Comparison of the effects of aerobic exercise and computer-based cognitive stimulation in patients with schizophrenia - A randomized controlled trial. J Psychiatr Res Koç , Koç EA, Ç, . PMID: 41621174 [PubMed - as supplied by publisher]
	Splitting schizophrenia: divergent cognitive and educational outcomes revealed by genomic structural equation modelling. Mol Psychiatry Watson CJ, Zvrskovec J, Merola GP, Gilchrist L, Haussler SM, Schattner M, Lo CWH, Breen G, Murray RM, Lewis C, Vassos E. PMID: 41620580 [PubMed - as supplied by publisher]
	Neuroinflammation: an unfortunate term to describe schizophrenia. Mol Psychiatry Llorca-Bofí V, Parellada E, Morén C, Sellgren CM, Bioque M. PMID: 41620579 [PubMed - as supplied by publisher]
	Aerobic glycolysis in Schizophrenia: Developmental rescue or energetic breakdown? Mol Psychiatry Memetoglu O, Goyal MS, Chouinard VA, Du F, Ongur D. PMID: 41620576 [PubMed - as supplied by publisher]
	Right orbitofrontal cortex rTMS targets anxiety, not depressive, symptoms in first-episode schizophrenia. J Affect Disord Yang Y, Hu Q, Jiao X, Wei Y, Cui H, Tang X, Xu L, Tang Y, Liu H, Gao J, Zeng L, Li C, Wang J, Zhang T. PMID: 41620181 [PubMed - as supplied by publisher]
	Predictive Value of C-Reactive Protein and Hematologic Ratios for Metabolic Syndrome in Schizophrenia. Span J Psychiatry Ment Health Sanchez-Autet M, Alfonso M, Hernandez C, Gonzalez-Blanco L, García-Portilla MP, Bernardo M, Anmella G, Amoretti S, Safont G, Arranz B. PMID: 41619939 [PubMed - as supplied by publisher]
	Investigating event-related potential (ERP) deviations in clinical high-risk populations for psychosis: a systematic review and meta-analysis. BMC Psychiatry Wei A, Gao R, Fan M, Luan P, Kong L, He X. PMID: 41618234 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 67936

Seite 1 von 3397



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung